• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Edwards Lifesciences

Edwards Lifesciences

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Australia Market Overview for Patient Monitoring Equipment 2017 - Research and Markets

    Australia Market Overview for Patient Monitoring Equipment 2017 - Research and Markets

  2. European Transcatheter Aortic Valve Implantation (TAVI) Market 2017: Essential Information about Reimbursement and National Funding for TAVI - Research and Markets

    European Transcatheter Aortic Valve Implantation (TAVI) Market 2017: Essential Information about Reimbursement and National Funding for TAVI - Research and Markets

  3. Structural Heart Devices Market to Reach $9 Billion by 2025 - Rapid Increase in Cardiovascular Conditions - Research and Markets

    Structural Heart Devices Market to Reach $9 Billion by 2025 - Rapid Increase in Cardiovascular Conditions - Research and Markets

  4. Global Transcatheter Mitral Valve Repair and Replacement Market 2017-2022: Asia Pacific Region to Witness the Fastest Growth in the Market - Research and Markets

    Global Transcatheter Mitral Valve Repair and Replacement Market 2017-2022: Asia Pacific Region to Witness the Fastest Growth in the Market - Research and Markets

  5. Coronary Artery Bypass Graft Market (2014-2025) - Analysis By Type, Surgical Procedures, Technology & Segment - Research and Markets

    Coronary Artery Bypass Graft Market (2014-2025) - Analysis By Type, Surgical Procedures, Technology & Segment - Research and Markets

  6. Which Funds Own My Stock?

    Ownership data provide a look at who else owns the company.

  7. No Surprises in Medtronic's Fiscal Third Quarter

    The firm is on track to meet our full-year estimates, and our $60 per share fair value estimate and wide moat rating are intact.

  8. A Contrarian Bent

    Disciplined Growth Investors’ managers have built a moderate allocation strategy unlike most others.

  9. 2014's Biggest Stock Winners: Is There Any Gas Left in the Tank?

    Declining fuel prices stoked great returns at several of these companies, but that's not a lasting advantage.

12

©2017 Morningstar Advisor. All right reserved.